Weeding out bad waves: Towards selective cannabinoid circuit control in epilepsy

Ivan Soltesz; Bradley E. Alger; Masanobu Kano; Sang Hun Lee; David M. Lovinger; Takako Ohno-Shosaku; Masahiko Watanabe

doi:10.1038/nrn3937

Weeding out bad waves: Towards selective cannabinoid circuit control in epilepsy

Ivan Soltesz, Bradley E. Alger, Masanobu Kano, Sang Hun Lee, David M. Lovinger, Takako Ohno-Shosaku, Masahiko Watanabe

Neuroscience

Research output: Contribution to journal › Review article › peer-review

113 Scopus citations

Abstract

Endocannabinoids are lipid-derived messengers, and both their synthesis and breakdown are under tight spatiotemporal regulation. As retrograde signalling molecules, endocannabinoids are synthesized postsynaptically but activate presynaptic cannabinoid receptor 1 (CB1) receptors to inhibit neurotransmitter release. In turn, CB1-expressing inhibitory and excitatory synapses act as strategically placed control points for activity-dependent regulation of dynamically changing normal and pathological oscillatory network activity. Here, we highlight emerging principles of cannabinoid circuit control and plasticity, and discuss their relevance for epilepsy and related comorbidities. New insights into cannabinoid signalling may facilitate the translation of the recent interest in cannabis-related substances as antiseizure medications to evidence-based treatment strategies.

Original language	English
Pages (from-to)	264-277
Number of pages	14
Journal	Nature Reviews Neuroscience
Volume	16
Issue number	5
DOIs	https://doi.org/10.1038/nrn3937
State	Published - Apr 20 2015

Bibliographical note

Funding Information:
The authors thank J. G. Malpeli for comments on the manuscript and M. Uchigashima for Figure 1c. This work was supported by a US National Institutes of Health grant (NS74432 to I.S.) and Grants-in-Aid for Scientific Research (23500466 to T.O.-S. and 25000015 to M.K.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.

Publisher Copyright:
© 2015 Macmillan Publishers Limited. All rights reserved.

ASJC Scopus subject areas

Neuroscience (all)

Access to Document

10.1038/nrn3937

Cite this

@article{9b48862eb98e4bcd8e963ad41964bd1c,

title = "Weeding out bad waves: Towards selective cannabinoid circuit control in epilepsy",

abstract = "Endocannabinoids are lipid-derived messengers, and both their synthesis and breakdown are under tight spatiotemporal regulation. As retrograde signalling molecules, endocannabinoids are synthesized postsynaptically but activate presynaptic cannabinoid receptor 1 (CB1) receptors to inhibit neurotransmitter release. In turn, CB1-expressing inhibitory and excitatory synapses act as strategically placed control points for activity-dependent regulation of dynamically changing normal and pathological oscillatory network activity. Here, we highlight emerging principles of cannabinoid circuit control and plasticity, and discuss their relevance for epilepsy and related comorbidities. New insights into cannabinoid signalling may facilitate the translation of the recent interest in cannabis-related substances as antiseizure medications to evidence-based treatment strategies.",

author = "Ivan Soltesz and Alger, {Bradley E.} and Masanobu Kano and Lee, {Sang Hun} and Lovinger, {David M.} and Takako Ohno-Shosaku and Masahiko Watanabe",

note = "Funding Information: The authors thank J. G. Malpeli for comments on the manuscript and M. Uchigashima for Figure 1c. This work was supported by a US National Institutes of Health grant (NS74432 to I.S.) and Grants-in-Aid for Scientific Research (23500466 to T.O.-S. and 25000015 to M.K.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. Publisher Copyright: {\textcopyright} 2015 Macmillan Publishers Limited. All rights reserved.",

year = "2015",

month = apr,

day = "20",

doi = "10.1038/nrn3937",

language = "English",

volume = "16",

pages = "264--277",

number = "5",

}

TY - JOUR

T1 - Weeding out bad waves

T2 - Towards selective cannabinoid circuit control in epilepsy

AU - Soltesz, Ivan

AU - Alger, Bradley E.

AU - Kano, Masanobu

AU - Lee, Sang Hun

AU - Lovinger, David M.

AU - Ohno-Shosaku, Takako

AU - Watanabe, Masahiko

N1 - Funding Information: The authors thank J. G. Malpeli for comments on the manuscript and M. Uchigashima for Figure 1c. This work was supported by a US National Institutes of Health grant (NS74432 to I.S.) and Grants-in-Aid for Scientific Research (23500466 to T.O.-S. and 25000015 to M.K.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. Publisher Copyright: © 2015 Macmillan Publishers Limited. All rights reserved.

PY - 2015/4/20

Y1 - 2015/4/20

N2 - Endocannabinoids are lipid-derived messengers, and both their synthesis and breakdown are under tight spatiotemporal regulation. As retrograde signalling molecules, endocannabinoids are synthesized postsynaptically but activate presynaptic cannabinoid receptor 1 (CB1) receptors to inhibit neurotransmitter release. In turn, CB1-expressing inhibitory and excitatory synapses act as strategically placed control points for activity-dependent regulation of dynamically changing normal and pathological oscillatory network activity. Here, we highlight emerging principles of cannabinoid circuit control and plasticity, and discuss their relevance for epilepsy and related comorbidities. New insights into cannabinoid signalling may facilitate the translation of the recent interest in cannabis-related substances as antiseizure medications to evidence-based treatment strategies.

AB - Endocannabinoids are lipid-derived messengers, and both their synthesis and breakdown are under tight spatiotemporal regulation. As retrograde signalling molecules, endocannabinoids are synthesized postsynaptically but activate presynaptic cannabinoid receptor 1 (CB1) receptors to inhibit neurotransmitter release. In turn, CB1-expressing inhibitory and excitatory synapses act as strategically placed control points for activity-dependent regulation of dynamically changing normal and pathological oscillatory network activity. Here, we highlight emerging principles of cannabinoid circuit control and plasticity, and discuss their relevance for epilepsy and related comorbidities. New insights into cannabinoid signalling may facilitate the translation of the recent interest in cannabis-related substances as antiseizure medications to evidence-based treatment strategies.

UR - http://www.scopus.com/inward/record.url?scp=84928104306&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928104306&partnerID=8YFLogxK

U2 - 10.1038/nrn3937

DO - 10.1038/nrn3937

M3 - Review article

C2 - 25891509

AN - SCOPUS:84928104306

SN - 1471-003X

VL - 16

SP - 264

EP - 277

JO - Nature Reviews Neuroscience

JF - Nature Reviews Neuroscience

IS - 5

ER -

Weeding out bad waves: Towards selective cannabinoid circuit control in epilepsy

Abstract

Bibliographical note

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this